Lorne B. Taichman MD, Msc, Phd

Lorne B. Taichman MD, MSc, PhD (631) 375-6604 www.emergingbiotech.com [email protected]

Professional Appointments Director of Science & Technology (part time), Windham Venture Partners, New York, NY, May 2006 to present  Identify and evaluate early and late stage opportunities for possible investment with a focus on medical devices, diagnostics, drug delivery and pharma research tools.  Engage in scientific due diligence and assist in formulating appropriate development strategy.

Corporate Associate, Corporate Office of Science and Technology (COSAT), Johnson & Johnson, New Brunswick, NJ, 2000 to 2001 (while on sabbatical leave from Stony Brook University)  Evaluated opportunities in cell/gene therapy, proteomics, metabolomics, ophthalmology, siRNA and other fields for Centocor, Cordis, DePuy, JJR (Australia), J&J Pharmaceutical Research and Development and Therakos.  Worked closely with J&J Development Corporation, the investment arm of J&J.  Explored investment, licensing and funding opportunities with academic investigators and university technology transfer offices.  Reported directly to Corporate Vice President and Chief Scientific Officer of J&J

Consultant, Corporate Office of Science and Technology (COSAT), Johnson & Johnson, New Brunswick, NJ, 2001 to 2006  Co-chaired COSAT’s cross-company Task Force on Cell Therapy and Regenerative Medicine.  Undertook state-of-science analyses in various therapeutic areas, including diabetes mellitus, cardiac disease, oncology, neurological disorders, orthopedics, and infectious diseases.  Participated as a member of COSAT’s Ophthalmology Task Force and siRNA Task Force.

Professor Emeritus, Department of Oral Biology and Pathology, School of Dental Medicine, Stony Brook University, Stony Brook, NY, 1974 to 2007  Directed an academic research laboratory focused on stem cells, epidermal cell biology and gene therapy.  As principal investigator, secured continuous grant support over a period of 30 years from governmental sources (e.g., NIH), private foundations (e.g., American Cancer Society) and pharmaceutical and cosmetic companies (e.g., J&J, Galderma and Estée Lauder).  Authored more than 65 manuscripts published in peer-reviewed journals.  Participated as an investigator in multi-center NIH-funded program project grants.  Developed unique teaching programs in clinical oral-facial genetics and cutaneous biology.  Co-founder of The Living Skin Bank, a New York State-funded hospital facility for treating burn victims with an autologous cell therapy product.  Served on Institutional Biosafety Committee, University Committee on Conflict of Interest, and Senate Committee on Research.

Additional Professional and Related Activities  Co-organized First International Workshop on Cutaneous Gene Therapy (NIH 2000) and Papillomavirus Workshop (Cold Spring Harbor Laboratory 1982).  Organized and chaired conference sessions on epithelial gene therapy at Gordon Research Conferences on Epidermal Differentiation and Keratinization.  Adjunct appointments in Departments of Dermatology at Stony Brook University and NYU Medical School.  Licensed to practice medicine in New York State.  Served as expert witness in the field of gene therapy for plaintiff, the prevailing party in patent infringement case.  Visiting Scientist, Papillomavirus Unit, Pasteur Institute, Paris, France (1982-1983).  Proficient in written and spoken French.

Education 1971 PhD (Molecular Biology) University of Wisconsin, Madison, Wisconsin 1967 MSc (Experimental Pathology) University of Toronto, Toronto, Ontario 1965 MD University of Toronto, Toronto, Ontario

(References available upon request)